Nicotinell Mint (Nicotine Polacrilex)

Nicotine Polacrilex, the active ingredient in Nicotinell Mint, is a nicotine replacement therapy presented as a buccal formulation for oral mucosa use. It is available across the European market and approved for over‑the‑counter sale. It is intended to help adult smokers manage nicotine withdrawal and reduce cravings during a quit attempt.

GNH USA supplies Nicotinell Mint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies, hospitals, and clinics worldwide with reliable quality and regulatory compliance. Our global distribution network ensures timely delivery and compliance with local regulatory requirements.

Nicotinell Mint, a nicotine replacement therapy, is used to address nicotine dependence and support smoking cessation.

- Smoking cessation: assists adult smokers in reducing withdrawal symptoms and cravings as part of a quit plan. - Nicotine dependence: provides controlled nicotine delivery to facilitate gradual reduction of tobacco use. - Relapse prevention: helps maintain abstinence by managing occasional cravings after quitting.

Nicotinell Mint may cause a range of oral and systemic reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation: mild soreness or tingling of the oral mucosa. - Hiccups: occasional involuntary diaphragm contractions. - Nausea: transient feeling of queasiness. - Throat irritation: mild scratchy sensation. - Headache: mild tension‑type headache.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or difficulty breathing. - Chest pain: unexpected cardiovascular discomfort. - Severe mouth ulcer: persistent ulceration requiring medical attention.

Before using Nicotinell Mint, consider the following precautions to ensure safe and effective use.

- Cardiovascular assessment: evaluate history of heart disease and consult a healthcare professional before starting. - Non‑smokers: avoid use in individuals who have never smoked nicotine, as it provides no therapeutic benefit. - Duration of therapy: limit use to the period recommended by a healthcare provider, typically not exceeding 12 weeks. - Pregnancy and breastfeeding: safety has not been established; discuss risks with a clinician. - Concomitant nicotine products: do not combine with other nicotine replacement therapies to prevent overdose. - Store at room temperature: keep in the original packaging, protect from moisture and heat.

Nicotinell Mint can interact with certain medications; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): concurrent use may increase risk of hypertensive episodes. - Other nicotine replacement products: combined use can lead to nicotine toxicity.

Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors (e.g., methoxsalen): may alter nicotine metabolism, requiring monitoring. - Antidepressants (SSRIs, SNRIs): monitor for enhanced side effects such as nausea or dizziness. - Alcohol: concurrent consumption may intensify nicotine’s cardiovascular effects.